Introduction
The incidence of fungal infections is increasing at an alarming rate, presenting an enormous challenge to healthcare professionals. This increase is directly related to the growing population of immunocompromised individuals, resulting from changes in medical practice such as the use of intensive chemotherapy and immunosuppressive drugs. 1 The most common fungal infections of humans are caused by the Candida, Cryptococcus and Aspergillus species. 2, 3 In addition, gains in many areas of these disease controls are seriously jeopardized by the emergence of drug-resistant clinical isolates to the available drugs. 4 Treatment of deeply invasive infections has consistently lagged behind chemotherapy; new approaches are urgently needed for improved diagnosis, including species identification, rapid and predictive susceptibility assays, and effective treatment 5 . In view of the above and as part of the our ongoing research on electron rich nitrogen heterocycle system comprises 1,3,5-triazine antimicrobials, which is 5-aza-bioisoster of purine is an important pharmacophore and privileged structure in medicinal chemistry, and anticancer agents. 9 However, data concerning antifungal activities of these compounds are very limited. 10 The continuous demand to develop efficient synthetic methods has prompted the researchers to use 1,3,5-triazine as a cheap reactive for many group transformations.
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Thiazole is another considerable pharmacophore group and has been reported to exhibit a variety of biological activities including antibacterial and antifungal anthelmintic. 12 On the basis of immense pharmacological action triazine and thiazole, it is noteworthy to synthesize these leads by clubbing together and to screen them for potential antifungal activity.
Furthermore, after extensive literature search, it was observed that, till date enough efforts have not been made to combine these two vital moieties as a single molecular scaffold and to study its antifungal activity. In our earlier work, we have developed some amino triazine derivatives bearing thiazole pendant, via nucleophilic substitution reaction of 1,3,5-triazine with various aromatic and substituted phenyl thiazole amines, as a novel potent antibacterial agent. 13, 14, 15 Prompted by these reports, and continuing to our interest in exploration of chemical and biological activities of 1,3,5-triazine derivatives, we herein, report in-vitro antifungal activities of these constitutive compounds, against few fungal species viz. Candida, Cryptococcus and Aspergillus.
Results and discussion
As depicted from table 1, compounds exhibits numerous degree of inhibition pattern on tested fungal species. Among the synthesized compound (1-6), moderate to no activity was observed with halogen substituted aromatic amines fragments along with substituted phenyl thiazole amines. Out of which, molecule having di-(4-chloro phenyl amine) with 4-nitro phenyl thiazole amine side chains (3), posses no activity against fungal species. Significant activity was achieved in case of analogue having di-halogen phenyl amine fragment 1 and 2 (3-chloro,4-phenyl amine). And further 4-chloro phenyl thiazole amine 1 was found more active (MFC=2.50 for A. niger equivalent to fluconazole) than their corresponding 4-nitro phenyl thiazole amine derivative 2. Compound 6, posses no activity against all tested microorganism although it contain 4-nitro phenyl thiazole amine side chain.
These finding indicates that, presence of hydrophobic fragments and electron withdrawing groups could modulate the antifungal activity of test compounds. The reason for this result may be explained by electron density of the compounds. It has been reported that electron-donating groups increase the electron density which makes the compounds effective against microorganisms and enhances the antibacterial activity. 16 However, high electron density causes more difficult diffusion through the fungal cell and substantial activity loss may occur. 17 Thus, for a compound an optimum electron density is inevitable so as to gain a significant antibacterial activity.
Conclusion
During the course of study, varyingly substituted 1,3,5-triazines were screened for their antifungal activity. It obvious from Structure Activity Profile that, antifungal activity of these tri-substituted triazines is associated with their individual triazine nucleus as well as the phenyl thiazole motifs in their hybrid skeletons.
In the light of above said we can say that for effective triazine antifungal agent, it should have di hydrophobic fragment with electron withdrawing atom on phenyl of thiazole side chain and showed the importance of electronic environment on antimicrobial activity.
Findings from the SAR studies have encouraged us to make some modifications on basic skeleton of the obtained leads to achieve efficacious and potent and derivatives in ongoing studies. In addition, for further investigations these findings can have a good approach on scientists to synthesize similar analogues.
Experimental

Antifungal activity
The synthesized compounds, trisubstituted 1,3,5-triazine derivatives were screened for their antifungal activity (MIC and MFC) against four fungi viz. Candida species (C. albicans NCIM-3102, C. glabrata NCIM-3266), Cryptococcus neoformans NCIM-3542, and Aspergillus niger NCIM-620 using modified broth microdilution method recommended by CLSI, 18, 19 The Candida spp. and C. neoformans suspensions were diluted with modified broth, RPMI 1640 medium at pH 4.5 in comparison to 0.5 McFarland standard to afford final target inocula of 5.0×10 3 and 5.0×10 5 for Candida spp. and C. neoformans respectively and A. niger inoculum was made to 4.0×10 4 colony forming units (CFU)/ml at pH 7.3 with the same RPMI 1640 medium in 5% Alamar blue. The fungal inocula were added to the samples to achieve a final volume of 200 µL. Eight serial dilutions, starting with 20.0000 µg/ml of the compounds (dissolved in dimethyl sulfoxide, DMSO) were made using 20% dimethyl sulfoxide in normal saline to afford least concentration of 0.1563 µg/ml (=0.16 µg/ml) and transferred in duplicate to 96-well flat-bottom microplates. All organisms were examined at 630 nm prior to and after incubation (Candida spp. at 37°C±1°C, 18 to 24 h; while for C. neoformans and A. niger at 35°C±1°C, 72 h). The lowest test concentration that allowed no detectable growth (or no more than 20% growth for Fluconazole, for A. niger, no color change from blue to pink) was defined as the minimum inhibitory concentration (MIC). Minimum fungicidal concentrations (MFCs) were determined by removing 5 µl from each clear (or blue) well, transferring to relevant agar, and incubating as previously mentioned. The MFC was defined as the lowest test concentration that allows no growth of the organism on agar. 
